J and J Snack Foods News

Current antidepressants take weeks or months to have an effect, and then only in 30% of patients, notes Matthew Herper, Forbes, in a recent post .

Until joining the company a few years ago, J&J neuroscience R&D head Husseini Manji led the mood and anxiety disorders program at the National Institutes of Health .

I'm at Johnson & Johnson 's Pharmaceutical Business Review today. Most of the day is dedicated to geeky drug R&D stuff, but Joaquin Duato started of the morning with a run-down of how J&J's pharmaceutical division is doing in terms of cold, hard sales.

Johnson & Johnson is developing what could eventually be game-changing treatments for depression and pain, and it's aiming to apply for approval of more than 10 new medicines by 2017, executives said Thursday during a review of the health care giant's medicine business.

BIG PLANS: Johnson & Johnson says it's poised by 2017 to seek regulatory approval for a dozen new medicines and two dozen variations of existing ones.

Johnson & Johnson, the world's biggest maker of health-care products, anticipates submitting more than 10 new medicines for approval by regulators worldwide by 2017.

Johnson & Johnson says it plans to submit more than 10 new treatments to regulators for approval and 25 applications for additional uses of approved drugs by 2017.

Johnson & Johnson says it plans to submit more than 10 new treatments to regulators for approval and 25 applications for additional uses of approved drugs by 2017.

The single, easiest way to keep track of all the stocks that matter... Your own personalized stock watchlist! It's a 100% FREE Motley Fool service... The wealth-building power of compound interest will never cease to amaze me.

Johnson & Johnson, the world's biggest maker of health-care products, said it will stop selling metal-on-metal and ceramic-on-metal hip replacements as demand wanes for the devices and U.S. regulators seek new rules.

A recent Third Circuit case brings good news for defendants making express preemption arguments under the Food, Drug and Cosmetic Act in misbranding class actions.

J&J Snack Foods Corporation sells a variety of branded and private label baked goods and food items.

The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy.

As economic growth averaging more than 7 percent a year helped shrink the number of chronically hungry, the population of overweight and obese Indians has climbed.

A group from the Las Vegas Convention and Visitors Authority just returned from a tour of Latin America.

Matthew is a member of The Motley Fool Blog Network -- entries represent the personal opinion of the blogger and are not formally edited.

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! Health officials have revoked Johnson & Johnson's license to make cosmetics at a plant outside Mumbai after they discovered the company had used an unauthorized process for sterilizing its baby powder.

Author Dan Heath - who scribed the best seller "Switch: How to Change Things When Change is Hard - consulted the University of Dayton Center for Leadership for his newest book, "Decisive," which is a management and leadership book.

The good news for J&J is that no U.S. products were affected, and that they identified the machines responsible for the failure.

"We understand their concerns and are diligently working with them to resolve the issue," Peggy Ballman, a J&J spokeswoman, said in a statement, adding that there were no consumer complaints or adverse events reported due to its use of the process.